2024 / 02

Next Paper
DOI: 10.24075/brsmu.2024.018
Copyright: © 2024 by the authors. Licensee: Pirogov University.
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).

ORIGINAL RESEARCH

Potentially inappropriate prescribing among critically ill children: POPI-criteria in Russia

Vlasova AV1,2,3, Kulichenko TV4, Smirnova EV2
About authors

1 Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of the Russian Federation, Moscow, Russia

2 Morozov Children's City Clinical Hospital, Moscow, Russia

3 Research Institute of Healthcare Organization and Medical Management, Moscow, Russia

4 Pirogov Russian National Research Medical University, Moscow, Russia

Correspondence should be addressed: Anna V. Vlasova
4th Dobryninsky pereulok, 1/9, Moscow,119049, Russia; ur.liam@57avosalvanna

About paper

Author contribution: Vlasova AV — study concept and design, data acquisition and processing, manuscript writing and editing; Smirnova EV — statistical data processing, manuscript editing; Kulichenko TV — manuscript editing.

Compliance with ethical standards: the study was approved by the Ethics Committee of the Morozov Children's City Clinical Hospital (the research protocol dated 24.10.2019 was published on ClinicalTrials.gov, ID: NCT04141657, Unique Protocol ID: 07819001, Brief Title: Safety Analysis of Antimicrobial Pharmacotherapy in Intensive Care Unit at Pediatric Hospital Official, Title: Observational Prospective Multidirectional Study on the Safety of Antimicrobial Pharmacotherapy in Intensive Care Unit (ICU) Children Aged 0-17).

Received: 2024-02-21 Accepted: 2024-04-27 Published online: 2024-04-30
|
  1. Impicciatore P, Choonara I, Clarkson A, Provasi D, Pandolfini C, Bonati M. Incidence of adverse drug reactions in paediatric in/outpatients: a systematic review and meta‐analysis of prospective studies. Br J Clin Pharmacol. 2001; 52 (1): 77–83.
  2. Li S, Huang L, Zeng L, Yu D, Jia ZJ, Cheng G, et al. A tool for screening potentially inappropriate prescribing in Chinese children. Front Pharmacol. 2022; 13: 1019795.
  3. Zhao Z, Shen J, Shen C, Zhu B, Sun J, Yu J,et al. An investigation of pharmacovigilance and reporting of adverse drug reactions in hospitals: a cross-sectional study in China. Curr Med Res Opin. 2021; 37 (11): 2001–6.
  4. Balan S, Hassali MAA, Mak VS. Two decades of off-label prescribing in children: a literature review. World J Pediatr. 2018; 14: 528–40.
  5. Berthe-Aucejo A, Nguyen PKH, Angoulvant F, Bellettre X, Albaret P, Weil T, et al. Retrospective study of irrational prescribing in French paediatric hospital: prevalence of inappropriate prescription detected by Pediatrics: Omission of Prescription and Inappropriate prescription (POPI) in the emergency unit and in the ambulatory setting. BMJ Open. 2019; 9 (3): e019186.
  6. Prot-Labarthe S, Weil T, Angoulvant F, Boulkedid R, Alberti C, Bourdon O. POPI (Pediatrics: Omission of Prescriptions and Inappropriate prescriptions): development of a tool to identify inappropriate prescribing. PloS One. 2014; 9 (6): e101171.
  7. Barry A, Olsson S, Minzi O, Bienvenu E, Makonnen E, Kamuhabwa A, et al. Comparative assessment of the national pharmacovigilance systems in East Africa: Ethiopia, Kenya, Rwanda and Tanzania. Drug Saf. 2020; 43: 339–50.
  8. Corrick FJ. Paediatric rational prescribing: a study of paediatric rational prescribing tools and development of a novel tool for the UK. 2021.
  9. Gallagher P, Ryan C, Byrne S, Kennedy J, O Mahony D. STOPP (screening tool of older person’s prescriptions) and START (screening tool to alert doctors to right treatment). Consensus validation. Int J Clin Pharmacol Ther. 2008; 46 (2): 72.
  10. Vlasova AV. Nezhelatel'nye reakcii detej na antimikrobnye preparaty: ogranichenija metoda spontannyh soobshhenij i vozmozhnosti metoda global'nyh triggerov lekarstvenno-inducirovannyh sostojanij. Farmateka. 2023 (1–2): 18–31. Russian.
  11. Jakovlev SV, Briko NI, Sidorenko SV, Procenko DN. Programma SKAT (strategija kontrolja antimikrobnoj terapii) pri okazanii stacionarnoj medicinskoj pomoshhi: Rossijskie klinicheskie rekomendacii. M.: Pero, 2018; 156 s. Russian.
  12. Centers for Disease Control and Prevention, CDC. Available from: https://www.cdc.gov/hai/vap/vap.html.
  13. European Centre for Disease Prevention and Control, ECDC. Available from: https://www.cdc.gov/hai/vap/vap.html.